Mark A. Lemmon, Ph.D.
Mark Lemmon is the David A. Sackler Professor of Pharmacology, and co-director of the Cancer Biology Institute at Yale University. Previously, he was the George W. Raiziss Professor and Chair of Biochemistry and Biophysics at the University of Pennsylvania Perelman School of Medicine, and an investigator in the Abramson Family Cancer Research Institute. Dr. Lemmon earned his B.A. in biochemistry from the University of Oxford (Hertford College), England, and his Ph.D. in molecular biophysics and biochemistry at Yale.
Dr. Lemmon’s laboratory focuses on mechanistic, structural, and biochemical aspects of signaling by growth factor receptor tyrosine kinases such as EGF receptor family members, and through phosphoinositides—having defined pleckstrin homology (PH) domain function, for example. He was elected as a Fellow of the Royal Society (FRS) in 2016.